Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease
Vande Casteele, Niels, Oyamada, Jun, Shimizu, Chisato, Best, Brookie M., Capparelli, Edmund V., Tremoulet, Adriana H., Burns, Jane C.
Published in Clinical pharmacokinetics (01.12.2018)
Published in Clinical pharmacokinetics (01.12.2018)
Get full text
Journal Article
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis
Ternant, David, Mulleman, Denis, Lauféron, Francine, Vignault, Céline, Ducourau, Emilie, Wendling, Daniel, Goupille, Philippe, Paintaud, Gilles
Published in British journal of clinical pharmacology (01.01.2012)
Published in British journal of clinical pharmacology (01.01.2012)
Get full text
Journal Article
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy
Choe, Jung-Yoon, Prodanovic, Nenad, Niebrzydowski, Jaroslaw, Staykov, Ivan, Dokoupilova, Eva, Baranauskaite, Asta, Yatsyshyn, Roman, Mekic, Mevludin, Porawska, Wieskawa, Ciferska, Hana, Jedrychowicz-Rosiak, Krystyna, Zielinska, Agnieszka, Choi, Jasmine, Rho, Young Hee, Smolen, Josef S
Published in Annals of the rheumatic diseases (01.01.2017)
Published in Annals of the rheumatic diseases (01.01.2017)
Get full text
Journal Article
A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade®) in Healthy Subjects
Shin, Donghoon, Kim, Youngdoe, Kim, Yoo Seok, Körnicke, Thomas, Fuhr, Rainard
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.12.2015)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.12.2015)
Get full text
Journal Article
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease
Bauman, Laura E, Xiong, Ye, Mizuno, Tomoyuki, Minar, Philip, Fukuda, Tsuyoshi, Dong, Min, Rosen, Michael J, Vinks, Alexander A
Published in Inflammatory bowel diseases (11.02.2020)
Published in Inflammatory bowel diseases (11.02.2020)
Get full text
Journal Article
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
Fabiani, Claudia, Vitale, Antonio, Emmi, Giacomo, Bitossi, Alice, Lopalco, Giuseppe, Sota, Jurgen, Guerriero, Silvana, Orlando, Ida, Capozzoli, Marco, Fusco, Fiorella, Rana, Francesco, Iannone, Florenzo, Frediani, Bruno, Galeazzi, Mauro, Vannozzi, Lorenzo, Tosi, Gian Marco, Cantarini, Luca
Published in Clinical rheumatology (01.01.2019)
Published in Clinical rheumatology (01.01.2019)
Get full text
Journal Article
The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease
Chi, Lisa Yue, Zitomersky, Naamah Levy, Liu, Enju, Tollefson, Sophia, Bender-Stern, Julia, Naik, Snehal, Snapper, Scott, Bousvaros, Athos
Published in Inflammatory bowel diseases (18.05.2018)
Published in Inflammatory bowel diseases (18.05.2018)
Get full text
Journal Article
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects
Zhang, Tan, Chen, Guihong, Liu, Chang, Zu, Li’an, Wang, Qi, Wang, Yitong, Lv, Jie, An, Youzhong, Dong, Lihou, Cheng, Huiyang, Ren, Shengbin, Wang, Qian, Zheng, Qingshan, Song, Haifeng, Fang, Yi
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.02.2019)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.02.2019)
Get full text
Journal Article
Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis
Palaparthy, Rameshraja, Rehman, Muhammad I., von Richter, Oliver, Yin, Donghua
Published in Expert opinion on biological therapy (03.10.2019)
Published in Expert opinion on biological therapy (03.10.2019)
Get full text
Journal Article
Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
Sorrentino, Dario, Marino, Marco, Dassopoulos, Themistocles, Zarifi, Dimitra, Del Bianco, Tiziana
Published in PloS one (15.12.2015)
Published in PloS one (15.12.2015)
Get full text
Journal Article
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
Grišić, Ana‐Marija, Dorn‐Rasmussen, Maria, Ungar, Bella, Brynskov, Jørn, Ilvemark, Johan F. K. F., Bolstad, Nils, Warren, David J., Ainsworth, Mark A., Huisinga, Wilhelm, Ben‐Horin, Shomron, Kloft, Charlotte, Steenholdt, Casper
Published in United European gastroenterology journal (01.02.2021)
Published in United European gastroenterology journal (01.02.2021)
Get full text
Journal Article
Bioavailability, safety and immunogenicity of biosimilar infliximab (BOW015) compared to reference infliximab
Lambert, John, Wyand, Michael, Lassen, Cheryl, Shneyer, Lucy, Thomson, Elizabeth, Knight, Alastair, Willers, Joerg, Kay, Jonathan
Published in International journal of clinical pharmacology and therapeutics (01.04.2016)
Published in International journal of clinical pharmacology and therapeutics (01.04.2016)
Get full text
Journal Article
The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis
Hjortebjerg, Rikke, Thomsen, Karen L., Agnholt, Jørgen, Frystyk, Jan
Published in BMC gastroenterology (03.06.2019)
Published in BMC gastroenterology (03.06.2019)
Get full text
Journal Article